Jupiter Endovascular Treats First U.S. Patient with Vertex Pulmonary Embolectomy System
Jupiter Endovascular, Inc., a medical technology startup focused on pioneering endovascular procedures with its Endoportal Control™ platform, has announced the successful treatment of the first U.S. patient in the SPIRARE II pivotal study. This study evaluates the Vertex Pulmonary Embolectomy…
Vertex Updates on Kidney Programs at ASN Annual Congress
Vertex Pharmaceuticals (Nasdaq: VRTX) has shared updates on its pipeline for kidney diseases, including IgA nephropathy (IgAN), primary membranous nephropathy (pMN), and APOL1-mediated kidney disease (AMKD). The updates highlight the potential of Vertex’s investigational therapies, showcasing positive new data on…
Centene Corporation Reports Q3 2024 Results
Centene Corporation (NYSE: CNC) has announced its financial results for the third quarter ending September 30, 2024. Key highlights include: CEO Sarah M. London noted, “Our diversified portfolio has allowed us to successfully navigate a dynamic landscape this quarter. We…
Siemens Healthineers to Automate Patient Testing, Addressing Lab Workflow and Staffing Issues
Siemens Healthineers is revolutionizing clinical lab automation by consolidating 25 tasks typically performed manually by staff, significantly reducing manual workflow steps by 75%. Traditional lab automation relies on a track system to transport samples, but the Atellica Integrated Automation system…
HCA Healthcare Reports Q3 2024 Results
HCA Healthcare, Inc. (NYSE: HCA) has released its financial results for the third quarter ending September 30, 2024. Key Metrics: CEO Sam Hazen praised the team for their response to recent hurricanes, emphasizing their commitment to patient care. Q3 Performance…
CVS Health Foundation Addresses Care Barriers for Chronic Disease Patients in Atlanta
The CVS Health® Foundation has announced a $1.5 million funding initiative to enhance access to healthcare services, medically tailored meals, and transportation for chronic disease patients in Atlanta. This funding will support partnerships with Good Samaritan Health Center, Open Hand…
WellSky® Acquires Bonafide® to Enhance Home Medical Equipment Solutions
WellSky, a prominent technology company in health and community care, has announced its acquisition of Bonafide, a software solution designed for durable medical equipment (DME) and home medical equipment (HME) providers. This acquisition enhances WellSky’s presence in the DME/HME sector,…
Modalis Gets Orphan Drug Designation for MDL-101 in LAMA2-CMD
Modalis Therapeutics Corporation (Tokyo Stock Exchange: 4883, CEO: Haru Morita) has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to MDL-101, a novel precision medicine for congenital muscular dystrophy type 1A (LAMA2-CMD). Modalis…
Maze Therapeutics Announces Positive Phase 1 Results for MZE829 in APOL1 Kidney Disease
Maze Therapeutics, a biopharmaceutical company focused on developing precision medicines using human genetics, has announced positive results from the Phase 1 clinical trial of MZE829 in healthy volunteers. MZE829 is an oral small molecule that inhibits APOL1, which Maze is…
Pharmacy Automation Innovations Reduce Operational Costs
Amid fluctuating market conditions and regulatory changes, pharmacies can leverage automated production to enhance efficiency, boost profitability, and substantially lower operational costs. Pharmacy automation provider JFCRx™ has launched TruCard™, a multi-dose adherence blister card packaging and inspection system designed to…
Agomab Secures $89 Million in Series D Funding for Fibrosis Pipeline Expansion
Agomab Therapeutics NV has announced an $89 million (€82.1 million) Series D financing round, featuring contributions from new investors Sanofi and Invus, alongside support from existing investors. Agomab Therapeutics plans to use the $89 million from its Series D financing…
PFD Week 2024: Model Predicts Women’s Success with First-Line Incontinence Treatment
Axena Health, Inc., a medical device company focused on female pelvic health, has announced the development of a machine learning model that could help clinicians create personalized treatments for female pelvic floor disorders. Researchers from Massachusetts General Hospital, the Massachusetts…